Gene-Engineered Mosquito Trial Cleared by FDA for Florida StartBy
Mosquitoes could be used to fight Zika and other diseases
Trial in Key Haven can’t begin unless approved by local voters
Intrexon Corp.’s Oxitec unit was cleared by U.S. regulators to move ahead in Florida and release genetically engineered mosquitoes and study their ability mate with local mosquitoes and suppress the population, a tactic that could slow or stop the spread of Zika virus and other mosquito-borne diseases.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.